Lindsay A. Wieczorek - Publications

Affiliations: 
Washington University, Saint Louis, St. Louis, MO 
Area:
Endocrinology and Stress

8/114 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2013 Laryea G, Arnett MG, Wieczorek L, Muglia LJ. Site-specific modulation of brain glucocorticoid receptor and corticotropin-releasing hormone expression using lentiviral vectors. Molecular and Cellular Endocrinology. 371: 160-5. PMID 23261985 DOI: 10.1016/j.mce.2012.12.005  0.546
2012 Wieczorek L, Majumdar D, Wills TA, Hu L, Winder DG, Webb DJ, Muglia LJ. Absence of Ca2+-stimulated adenylyl cyclases leads to reduced synaptic plasticity and impaired experience-dependent fear memory. Translational Psychiatry. 2: e126. PMID 22832970 DOI: 10.1038/Tp.2012.50  0.516
2010 Wieczorek L, Maas JW, Muglia LM, Vogt SK, Muglia LJ. Temporal and regional regulation of gene expression by calcium-stimulated adenylyl cyclase activity during fear memory. Plos One. 5: e13385. PMID 20976279 DOI: 10.1371/Journal.Pone.0013385  0.614
2010 Kolber BJ, Boyle MP, Wieczorek L, Kelley CL, Onwuzurike CC, Nettles SA, Vogt SK, Muglia LJ. Transient early-life forebrain corticotropin-releasing hormone elevation causes long-lasting anxiogenic and despair-like changes in mice. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 30: 2571-81. PMID 20164342 DOI: 10.1523/Jneurosci.4470-09.2010  0.62
2010 McLaughlin KJ, Wilson JO, Harman J, Wright RL, Wieczorek L, Gomez J, Korol DL, Conrad CD. Chronic 17beta-estradiol or cholesterol prevents stress-induced hippocampal CA3 dendritic retraction in ovariectomized female rats: possible correspondence between CA1 spine properties and spatial acquisition. Hippocampus. 20: 768-86. PMID 19650122 DOI: 10.1002/Hipo.20678  0.616
2008 Kolber BJ, Wieczorek L, Muglia LJ. Hypothalamic-pituitary-adrenal axis dysregulation and behavioral analysis of mouse mutants with altered glucocorticoid or mineralocorticoid receptor function. Stress (Amsterdam, Netherlands). 11: 321-38. PMID 18609295 DOI: 10.1080/10253890701821081  0.633
2007 Conrad CD, McLaughlin KJ, Harman JS, Foltz C, Wieczorek L, Lightner E, Wright RL. Chronic glucocorticoids increase hippocampal vulnerability to neurotoxicity under conditions that produce CA3 dendritic retraction but fail to impair spatial recognition memory. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 27: 8278-85. PMID 17670974 DOI: 10.1523/Jneurosci.2121-07.2007  0.609
2004 Conrad CD, Jackson JL, Wieczorek L, Baran SE, Harman JS, Wright RL, Korol DL. Acute stress impairs spatial memory in male but not female rats: influence of estrous cycle. Pharmacology, Biochemistry, and Behavior. 78: 569-79. PMID 15251266 DOI: 10.1016/J.Pbb.2004.04.025  0.617
Low-probability matches (unlikely to be authored by this person)
2015 Wieczorek L, Fish EW, O'Leary-Moore SK, Parnell SE, Sulik KK. Hypothalamic-pituitary-adrenal axis and behavioral dysfunction following early binge-like prenatal alcohol exposure in mice. Alcohol (Fayetteville, N.Y.). 49: 207-17. PMID 25709101 DOI: 10.1016/J.Alcohol.2015.01.005  0.294
2009 Sadowski RN, Jackson GR, Wieczorek L, Gold PE. Effects of stress, corticosterone, and epinephrine administration on learning in place and response tasks. Behavioural Brain Research. 205: 19-25. PMID 19555723 DOI: 10.1016/J.Bbr.2009.06.027  0.287
2016 Fish EW, Holloway HT, Rumple A, Baker LK, Wieczorek LA, Moy SS, Paniagua B, Parnell SE. Acute alcohol exposure during neurulation: behavioral and brain structural consequences in adolescent C57BL/6J mice. Behavioural Brain Research. PMID 27185739 DOI: 10.1016/J.Bbr.2016.05.004  0.231
1984 Hesse JE, Wieczorek L, Altendorf K, Reicin AS, Dorus E, Epstein W. Sequence homology between two membrane transport ATPases, the Kdp-ATPase of Escherichia coli and the Ca2+-ATPase of sarcoplasmic reticulum. Proceedings of the National Academy of Sciences of the United States of America. 81: 4746-50. PMID 6146979 DOI: 10.1073/Pnas.81.15.4746  0.102
2023 Marichannegowda MH, Zemil M, Wieczorek L, Sanders-Buell E, Bose M, O'Sullivan AM, King D, Francisco L, Diaz-Mendez F, Setua S, Chomont N, Phanuphak N, Ananworanich J, Hsu D, Vasan S, et al. Tracking coreceptor switch of the transmitted/founder HIV-1 identifies co-evolution of HIV-1 antigenicity, coreceptor usage and CD4 subset targeting. Biorxiv : the Preprint Server For Biology. PMID 36712089 DOI: 10.1101/2023.01.21.525033  0.1
2023 Chen WH, Hajduczki A, Martinez EJ, Bai H, Matz H, Hill TM, Lewitus E, Chang WC, Dawit L, Peterson CE, Rees PA, Ajayi AB, Golub ES, Swafford I, Dussupt V, ... ... Wieczorek L, et al. Shark nanobodies with potent SARS-CoV-2 neutralizing activity and broad sarbecovirus reactivity. Nature Communications. 14: 580. PMID 36737435 DOI: 10.1038/s41467-023-36106-x  0.095
2008 Kohlmann A, Kipps TJ, Rassenti LZ, Downing JR, Shurtleff SA, Mills KI, Gilkes AF, Hofmann WK, Basso G, Dell'orto MC, Foà R, Chiaretti S, De Vos J, Rauhut S, Papenhausen PR, ... ... Wieczorek L, et al. An international standardization programme towards the application of gene expression profiling in routine leukaemia diagnostics: the Microarray Innovations in LEukemia study prephase. British Journal of Haematology. 142: 802-7. PMID 18573112 DOI: 10.1111/j.1365-2141.2008.07261.x  0.095
2021 Joyce MG, Chen WH, Sankhala RS, Hajduczki A, Thomas PV, Choe M, Martinez EJ, Chang WC, Peterson CE, Morrison EB, Smith C, Chen RE, Ahmed A, Wieczorek L, Anderson A, et al. SARS-CoV-2 ferritin nanoparticle vaccines elicit broad SARS coronavirus immunogenicity. Cell Reports. 110143. PMID 34919799 DOI: 10.1016/j.celrep.2021.110143  0.092
2021 Joyce MG, Chen WH, Sankhala RS, Hajduczki A, Thomas PV, Choe M, Chang W, Peterson CE, Martinez E, Morrison EB, Smith C, Ahmed A, Wieczorek L, Anderson A, Chen RE, et al. SARS-CoV-2 ferritin nanoparticle vaccines elicit broad SARS coronavirus immunogenicity. Biorxiv : the Preprint Server For Biology. PMID 34013273 DOI: 10.1101/2021.05.09.443331  0.091
2023 Kuriakose Gift S, Wieczorek L, Sanders-Buell E, Zemil M, Molnar S, Donofrio G, Townsley S, Chenine AL, Bose M, Trinh HV, Barrows BM, Sriplienchan S, Kitsiripornchai S, Nitayapan S, Eller LA, et al. Evolution of Antibody Responses in HIV-1 CRF01_AE Acute Infection: Founder Envelope V1V2 Impacts the Timing and Magnitude of Autologous Neutralizing Antibodies. Journal of Virology. e0163522. PMID 36749076 DOI: 10.1128/jvi.01635-22  0.09
1990 Merchav S, Nielsen OJ, Rosenbaum H, Sharon R, Brenner B, Tatarsky I, Scigalla P, Wieczorek L. In vitro studies of erythropoietin-dependent regulation of erythropoiesis in myelodysplastic syndromes. Leukemia. 4: 771-4. PMID 2232891  0.09
2023 Song H, Marichannegowda M, Setua S, Bose M, Sanders-Buell E, King D, Zemil M, Wieczorek L, Diaz-Mendez F, Chomont N, Thomas R, Francisco L, Eller LA, Polonis V, Tovanabutra S, et al. Transmission of highly virulent CXCR4 tropic HIV-1 through the mucosal route in an individual with a wild-type CCR5 genotype. Research Square. PMID 37841838 DOI: 10.21203/rs.3.rs-3359209/v1  0.088
2023 Marichannegowda MH, Setua S, Bose M, Sanders-Buell E, King D, Zemil M, Wieczorek L, Diaz-Mendez F, Chomont N, Thomas R, Francisco L, Eller LA, Polonis VR, Tovanabutra S, Tagaya Y, et al. Transmission of highly virulent CXCR4 tropic HIV-1 through the mucosal route in an individual with a wild-type CCR5 genotype. Biorxiv : the Preprint Server For Biology. PMID 37745406 DOI: 10.1101/2023.09.15.557832  0.088
2022 Barrows BM, Krebs SJ, Jian N, Zemil M, Slike BM, Dussupt V, Tran U, Mendez-Rivera L, Chang D, O'Sullivan AM, Mann B, Sanders-Buell E, Shubin Z, Creegan M, Paquin-Proulx D, ... ... Wieczorek L, et al. Fc receptor engagement of HIV-1 Env-specific antibodies in mothers and infants predicts reduced vertical transmission. Frontiers in Immunology. 13: 1051501. PMID 36578481 DOI: 10.3389/fimmu.2022.1051501  0.087
2009 Blanco JC, Pletneva LM, Wieczorek L, Khetawat D, Stantchev TS, Broder CC, Polonis VR, Prince GA. Expression of Human CD4 and chemokine receptors in cotton rat cells confers permissiveness for productive HIV infection. Virology Journal. 6: 57. PMID 19442298 DOI: 10.1186/1743-422X-6-57  0.086
2020 Om K, Paquin-Proulx D, Montero M, Peachman K, Shen X, Wieczorek L, Beck Z, Weiner JA, Kim D, Li Y, Mdluli T, Shubin Z, Bryant C, Sharma V, Tokarev A, et al. Adjuvanted HIV-1 vaccine promotes antibody-dependent phagocytic responses and protects against heterologous SHIV challenge. Plos Pathogens. 16: e1008764. PMID 32881968 DOI: 10.1371/Journal.Ppat.1008764  0.085
2008 Kohlmann A, Haschke-Becher E, Wimmer B, Huber-Wechselberger A, Meyer-Monard S, Huxol H, Siegler U, Rossier M, Matthes T, Rebsamen M, Chiappe A, Diemand A, Rauhut S, Johnson A, Liu WM, ... ... Wieczorek L, et al. Intraplatform reproducibility and technical precision of gene expression profiling in 4 laboratories investigating 160 leukemia samples: the DACH study. Clinical Chemistry. 54: 1705-15. PMID 18719197 DOI: 10.1373/clinchem.2008.108506  0.081
2013 Chenine AL, Wieczorek L, Sanders-Buell E, Wesberry M, Towle T, Pillis DM, Molnar S, McLinden R, Edmonds T, Hirsch I, O'Connell R, McCutchan FE, Montefiori DC, Ochsenbauer C, Kappes JC, et al. Impact of HIV-1 backbone on neutralization sensitivity: neutralization profiles of heterologous envelope glycoproteins expressed in native subtype C and CRF01_AE backbone. Plos One. 8: e76104. PMID 24312165 DOI: 10.1371/Journal.Pone.0076104  0.08
2021 Dussupt V, Sankhala RS, Mendez-Rivera L, Townsley SM, Schmidt F, Wieczorek L, Lal KG, Donofrio GC, Tran U, Jackson ND, Zaky WI, Zemil M, Tritsch SR, Chen WH, Martinez EJ, et al. Low-dose in vivo protection and neutralization across SARS-CoV-2 variants by monoclonal antibody combinations. Nature Immunology. PMID 34716452 DOI: 10.1038/s41590-021-01068-z  0.08
2021 Mitchell JL, Pollara J, Dietze K, Edwards RW, Nohara J, N'guessan KF, Zemil M, Buranapraditkun S, Takata H, Li Y, Muir R, Kroon E, Pinyakorn S, Jha S, Manasnayakorn S, ... ... Wieczorek L, et al. Anti-HIV antibody development up to one year after antiretroviral therapy initiation in acute HIV infection. The Journal of Clinical Investigation. PMID 34762600 DOI: 10.1172/JCI150937  0.079
2013 McLinden RJ, Labranche CC, Chenine AL, Polonis VR, Eller MA, Wieczorek L, Ochsenbauer C, Kappes JC, Perfetto S, Montefiori DC, Michael NL, Kim JH. Detection of HIV-1 neutralizing antibodies in a human CD4⁺/CXCR4⁺/CCR5⁺ T-lymphoblastoid cell assay system. Plos One. 8: e77756. PMID 24312168 DOI: 10.1371/Journal.Pone.0077756  0.076
2023 King HAD, Dussupt V, Mendez-Rivera L, Slike BM, Tran U, Jackson ND, Barkei E, Zemil M, Tourtellott-Fogt E, Kuklis CH, Soman S, Ahmed A, Porto M, Kitajewski C, Spence B, ... ... Wieczorek L, et al. Convalescent human IgG, but not IgM, from COVID-19 survivors confers dose-dependent protection against SARS-CoV-2 replication and disease in hamsters. Frontiers in Immunology. 14: 1138629. PMID 37026013 DOI: 10.3389/fimmu.2023.1138629  0.075
2023 Sankhala RS, Dussupt V, Chen WH, Bai H, Martinez EJ, Jensen JL, Rees PA, Hajduczki A, Chang WC, Choe M, Yan L, Sterling SL, Swafford I, Kuklis C, Soman S, ... ... Wieczorek L, et al. Antibody targeting of conserved sites of vulnerability on the SARS-CoV-2 spike receptor-binding domain. Structure (London, England : 1993). PMID 38157856 DOI: 10.1016/j.str.2023.11.015  0.074
2014 Venditto VJ, Wieczorek L, Molnar S, Teque F, Landucci G, Watson DS, Forthal D, Polonis VR, Levy JA, Szoka FC. Chemically modified peptides based on the membrane-proximal external region of the HIV-1 envelope induce high-titer, epitope-specific nonneutralizing antibodies in rabbits. Clinical and Vaccine Immunology : Cvi. 21: 1086-93. PMID 24872518 DOI: 10.1128/Cvi.00320-14  0.072
2023 Costanzo MC, Paquin-Proulx D, Schuetz A, Akapirat S, Shubin Z, Kim D, Wieczorek L, Polonis VR, Trinh HV, Rao M, Anenia H, Barrera MD, Boeckelman J, Nails B, Thapa P, et al. ALVAC-HIV and AIDSVAX B/E vaccination induce improved immune responses compared with AIDSVAX B/E vaccination alone. Jci Insight. 8. PMID 37154156 DOI: 10.1172/jci.insight.167664  0.072
2010 Haferlach T, Kohlmann A, Wieczorek L, Basso G, Kronnie GT, Béné MC, De Vos J, Hernández JM, Hofmann WK, Mills KI, Gilkes A, Chiaretti S, Shurtleff SA, Kipps TJ, Rassenti LZ, et al. Clinical utility of microarray-based gene expression profiling in the diagnosis and subclassification of leukemia: report from the International Microarray Innovations in Leukemia Study Group. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 28: 2529-37. PMID 20406941 DOI: 10.1200/JCO.2009.23.4732  0.071
2022 Wieczorek L, Zemil M, Merbah M, Dussupt V, Kavusak E, Molnar S, Heller J, Beckman B, Wollen-Roberts S, Peachman KK, Darden JM, Krebs S, Rolland M, Peel SA, Polonis VR. Evaluation of Antibody-Dependent Fc-Mediated Viral Entry, as Compared With Neutralization, in SARS-CoV-2 Infection. Frontiers in Immunology. 13: 901217. PMID 35711449 DOI: 10.3389/fimmu.2022.901217  0.07
2006 Platt S, Freeman J, di Stefani A, Wieczorek L, Henley W. Prevalence of unilateral and bilateral deafness in border collies and association with phenotype. Journal of Veterinary Internal Medicine / American College of Veterinary Internal Medicine. 20: 1355-62. PMID 17186850 DOI: 10.1892/0891-6640(2006)20[1355:POUABD]2.0.CO;2  0.07
2015 Wieczorek L, Krebs SJ, Kalyanaraman V, Whitney S, Tovanabutra S, Moscoso CG, Sanders-Buell E, Williams C, Slike B, Molnar S, Dussupt V, Alam SM, Chenine AL, Tong T, Hill EL, et al. Comparable Antigenicity and Immunogenicity of Oligomeric Forms of a Novel, Acute HIV-1 Subtype C gp145 Envelope for Use in Preclinical and Clinical Vaccine Research. Journal of Virology. 89: 7478-93. PMID 25972551 DOI: 10.1128/Jvi.00412-15  0.07
2009 Matyas GR, Wieczorek L, Beck Z, Ochsenbauer-Jambor C, Kappes JC, Michael NL, Polonis VR, Alving CR. P05-04. Neutralizing antibodies induced by immunization with liposomal gp41 peptide simultaneously bind to both the 2F5 or 4E10 epitope and lipid epitopes Retrovirology. 6: P80. DOI: 10.1186/1742-4690-6-S3-P80  0.069
2009 Mills KI, Kohlmann A, Williams PM, Wieczorek L, Liu WM, Li R, Wei W, Bowen DT, Loeffler H, Hernandez JM, Hofmann WK, Haferlach T. Microarray-based classifiers and prognosis models identify subgroups with distinct clinical outcomes and high risk of AML transformation of myelodysplastic syndrome. Blood. 114: 1063-72. PMID 19443663 DOI: 10.1182/blood-2008-10-187203  0.068
2020 Colby DJ, Sarnecki M, Barouch DH, Tipsuk S, Stieh DJ, Kroon E, Schuetz A, Intasan J, Sacdalan C, Pinyakorn S, Grandin P, Song H, Tovanabutra S, Shubin Z, Kim D, ... ... Wieczorek L, et al. Safety and immunogenicity of Ad26 and MVA vaccines in acutely treated HIV and effect on viral rebound after antiretroviral therapy interruption. Nature Medicine. PMID 32235883 DOI: 10.1038/s41591-020-0774-y  0.067
2023 Jensen JL, Sankhala RS, Dussupt V, Bai H, Hajduczki A, Lal KG, Chang WC, Martinez EJ, Peterson CE, Golub ES, Rees PA, Mendez-Rivera L, Zemil M, Kavusak E, Mayer SV, ... Wieczorek L, et al. Targeting the Spike Receptor Binding Domain Class V Cryptic Epitope by an Antibody with Pan-Sarbecovirus Activity. Journal of Virology. e0159622. PMID 37395646 DOI: 10.1128/jvi.01596-22  0.066
2010 Edmonds TG, Ding H, Yuan X, Wei Q, Smith KS, Conway JA, Wieczorek L, Brown B, Polonis V, West JT, Montefiori DC, Kappes JC, Ochsenbauer C. Replication competent molecular clones of HIV-1 expressing Renilla luciferase facilitate the analysis of antibody inhibition in PBMC. Virology. 408: 1-13. PMID 20863545 DOI: 10.1016/J.Virol.2010.08.028  0.066
2013 Gao G, Wieczorek L, Peachman KK, Polonis VR, Alving CR, Rao M, Rao VB. Designing a soluble near full-length HIV-1 gp41 trimer. The Journal of Biological Chemistry. 288: 234-46. PMID 23184960 DOI: 10.1074/Jbc.M112.424432  0.066
1998 Woodhouse GE, King LG, Wieczorek L, Cornell BA. Kinetics of the competitive response of receptors immobilised to ion-channels which have been incorporated into a tethered bilayer. Faraday Discussions. 247-58; discussion 3. PMID 10822612  0.066
2010 Rosa Borges A, Wieczorek L, Johnson B, Benesi AJ, Brown BK, Kensinger RD, Krebs FC, Wigdahl B, Blumenthal R, Puri A, McCutchan FE, Birx DL, Polonis VR, Schengrund CL. Multivalent dendrimeric compounds containing carbohydrates expressed on immune cells inhibit infection by primary isolates of HIV-1. Virology. 408: 80-8. PMID 20880566 DOI: 10.1016/J.Virol.2010.09.004  0.065
2023 Wieczorek L, Sanders-Buell E, Zemil M, Lewitus E, Kavusak E, Heller J, Molnar S, Rao M, Smith G, Bose M, Nguyen A, Dhungana A, Okada K, Parisi K, Silas D, et al. Evolution of HIV-1 envelope towards reduced neutralization sensitivity, as demonstrated by contemporary HIV-1 subtype B from the United States. Plos Pathogens. 19: e1011780. PMID 38055771 DOI: 10.1371/journal.ppat.1011780  0.063
2018 Chenine AL, Merbah M, Wieczorek L, Molnar S, Mann B, Lee J, O'Sullivan AM, Bose M, Sanders-Buell E, Kijak GH, Herrera C, McLinden R, O'Connell RJ, Michael NL, Robb ML, et al. Neutralization Sensitivity of a Novel HIV-1 CRF01_AE Panel of Infectious Molecular Clones. Journal of Acquired Immune Deficiency Syndromes (1999). PMID 29528942 DOI: 10.1097/QAI.0000000000001675  0.063
2012 Brown BK, Wieczorek L, Kijak G, Lombardi K, Currier J, Wesberry M, Kappes JC, Ngauy V, Marovich M, Michael N, Ochsenbauer C, Montefiori DC, Polonis VR. The role of natural killer (NK) cells and NK cell receptor polymorphisms in the assessment of HIV-1 neutralization. Plos One. 7: e29454. PMID 22509241 DOI: 10.1371/Journal.Pone.0029454  0.059
2013 Wieczorek L, Brown BK, Delsarto Macedo C, Wesberry-Schmierer M, Ngauy V, Rosa Borges A, Michael NL, Marovich MA, Montefiori DC, Polonis VR. Mitigation of variation observed in a peripheral blood mononuclear cell (PBMC) based HIV-1 neutralization assay by donor cell pooling. Virology. 447: 240-8. PMID 24210120 DOI: 10.1016/j.virol.2013.09.014  0.059
2024 Sankhala RS, Lal KG, Jensen JL, Dussupt V, Mendez-Rivera L, Bai H, Wieczorek L, Mayer SV, Zemil M, Wagner DA, Townsley SM, Hajduczki A, Chang WC, Chen WH, Donofrio GC, et al. Diverse array of neutralizing antibodies elicited upon Spike Ferritin Nanoparticle vaccination in rhesus macaques. Nature Communications. 15: 200. PMID 38172512 DOI: 10.1038/s41467-023-44265-0  0.059
2020 Molnar S, Wieczorek L, Zemil M, Schulte B, Martinez E, Gift S, Tang L, Streeck H, Gramzinski RA, Michael NL, Joyce G, Polonis VR. Novel monoclonal antibodies to the SERINC5 HIV-1 restriction factor detect endogenous andvirion-associated SERINC5. Mabs. 12: 1802187. PMID 32835602 DOI: 10.1080/19420862.2020.1802187  0.059
2006 Wieczorek LA, Garosi LS, Shelton GD. Dystrophin-deficient muscular dystrophy in an old English sheepdog. The Veterinary Record. 158: 270-3. PMID 16501160  0.058
2020 Wieczorek L, Peachman K, Steers N, Schoen J, Rao M, Polonis V, Rao V. Selection and immune recognition of HIV-1 MPER mimotopes. Virology. 550: 99-108. PMID 32980676 DOI: 10.1016/j.virol.2020.06.016  0.058
2021 Wuertz KM, Barkei EK, Chen WH, Martinez EJ, Lakhal-Naouar I, Jagodzinski LL, Paquin-Proulx D, Gromowski GD, Swafford I, Ganesh A, Dong M, Zeng X, Thomas PV, Sankhala RS, Hajduczki A, ... ... Wieczorek L, et al. A SARS-CoV-2 spike ferritin nanoparticle vaccine protects hamsters against Alpha and Beta virus variant challenge. Npj Vaccines. 6: 129. PMID 34711815 DOI: 10.1038/s41541-021-00392-7  0.056
2009 Beck Z, Brown BK, Wieczorek L, Peachman KK, Matyas GR, Polonis VR, Rao M, Alving CR. Human erythrocytes selectively bind and enrich infectious HIV-1 virions. Plos One. 4: e8297. PMID 20011536 DOI: 10.1371/journal.pone.0008297  0.055
2014 Swi?tkiewicz G, Wieczorek L, Allamani A. What influences changes in alcoholic beverage consumption over time? Poland in the light of the European Union Amphora study. Substance Use & Misuse. 49: 1601-10. PMID 24832915 DOI: 10.3109/10826084.2014.914376  0.055
2016 Emmer KL, Wieczorek L, Tuyishime S, Molnar S, Polonis VR, Ertl HC. Antibody responses to prime-boost vaccination with an HIV-1 gp145 Env protein and chimpanzee adenovirus vectors expressing HIV-1 gp140. Aids (London, England). PMID 27525550 DOI: 10.1097/Qad.0000000000001224  0.054
2008 Brown BK, Wieczorek L, Sanders-Buell E, Rosa Borges A, Robb ML, Birx DL, Michael NL, McCutchan FE, Polonis VR. Cross-clade neutralization patterns among HIV-1 strains from the six major clades of the pandemic evaluated and compared in two different models. Virology. 375: 529-38. PMID 18433824 DOI: 10.1016/j.virol.2008.02.022  0.054
2010 Matyas GR, Wieczorek L, Bansal D, Chenine AL, Sanders-Buell E, Tovanabutra S, Kim JH, Polonis V, Alving CR. Inhibition of HIV-1 infection of peripheral blood mononuclear cells by a monoclonal antibody that binds to phosphoinositides and induces secretion of β-chemokines. Biochemical and Biophysical Research Communications. 402: 808-12. PMID 21040700 DOI: 10.1016/j.bbrc.2010.10.124  0.054
2023 Marichannegowda MH, Zemil M, Wieczorek L, Sanders-Buell E, Bose M, O'Sullivan AM, King D, Francisco L, Diaz-Mendez F, Setua S, Chomont N, Phanuphak N, Ananworanich J, Hsu D, Vasan S, et al. Tracking coreceptor switch of the transmitted/founder HIV-1 identifies co-evolution of HIV-1 antigenicity, coreceptor usage and CD4 subset targeting: the RV217 acute infection cohort study. Ebiomedicine. 98: 104867. PMID 37939456 DOI: 10.1016/j.ebiom.2023.104867  0.053
2009 Matyas GR, Wieczorek L, Beck Z, Ochsenbauer-Jambor C, Kappes JC, Michael NL, Polonis VR, Alving CR. Neutralizing antibodies induced by liposomal HIV-1 glycoprotein 41 peptide simultaneously bind to both the 2F5 or 4E10 epitope and lipid epitopes. Aids (London, England). 23: 2069-77. PMID 19710597 DOI: 10.1097/Qad.0B013E32832Faea5  0.052
2014 Nilsson C, Godoy-Ramirez K, Hejdeman B, BrÃ¥ve A, Gudmundsdotter L, Hallengärd D, Currier JR, Wieczorek L, Hasselrot K, Earl PL, Polonis VR, Marovich MA, Robb ML, Sandström E, Wahren B, et al. Broad and potent cellular and humoral immune responses after a second late HIV-modified vaccinia virus ankara vaccination in HIV-DNA-primed and HIV-modified vaccinia virus Ankara-boosted Swedish vaccinees. Aids Research and Human Retroviruses. 30: 299-311. PMID 24090081 DOI: 10.1089/AID.2013.0149  0.052
2003 Tankó LB, Mouritzen U, Lehmann HJ, Warming L, Moelgaard A, Christgau S, Qvist P, Baumann M, Wieczorek L, Hoyle N, Christiansen C. Oral ibandronate: changes in markers of bone turnover during adequately dosed continuous and weekly therapy and during different suboptimally dosed treatment regimens. Bone. 32: 687-93. PMID 12810176  0.052
2024 N'guessan KF, Machmach K, Swafford I, Costanzo MC, Wieczorek L, Kim D, Akapirat S, Polonis VR, Pitisuttithum P, Nitayaphan S, Gurunathan S, Sinangil F, Chariyalertsak S, Ake JA, O'connell RJ, et al. Innate immune cell activation after HIV-1 vaccine administration is associated with increased antibody production. Frontiers in Immunology. 15: 1339727. PMID 38420129 DOI: 10.3389/fimmu.2024.1339727  0.052
2020 Wieczorek L, Peachman K, Adams DJ, Barrows B, Molnar S, Schoen J, Dawson P, Bryant C, Chenine AL, Sanders-Buell E, Srithanaviboonchai K, Pathipvanich P, Michael NL, Robb ML, Tovanabutra S, et al. Evaluation of HIV-1 neutralizing and binding antibodies in maternal-infant transmission in Thailand. Virology. 548: 152-159. PMID 32838936 DOI: 10.1016/j.virol.2020.05.007  0.051
2010 Peachman KK, Wieczorek L, Polonis VR, Alving CR, Rao M. The effect of sCD4 on the binding and accessibility of HIV-1 gp41 MPER epitopes to human monoclonal antibodies. Virology. 408: 213-23. PMID 20961591 DOI: 10.1016/j.virol.2010.09.029  0.051
2009 Brown BK, Lombardi K, Bryson M, Currier J, Thelian D, Wieczorek L, Kijak G, Kappes JC, Ochsenbauer-Jambor C, Michael NL, Montefiori D, Polonis VR. P04-12. Characterization of leukopak PBMC phenotypes and biotypes for optimal performance in HIV-1 neutralization assays Retrovirology. 6: P40. DOI: 10.1186/1742-4690-6-S3-P40  0.05
2007 Müller MC, Saglio G, Lin F, Pfeifer H, Press RD, Tubbs RR, Paschka P, Gottardi E, O'Brien SG, Ottmann OG, Stockinger H, Wieczorek L, Merx K, König H, Schwindel U, et al. An international study to standardize the detection and quantitation of BCR-ABL transcripts from stabilized peripheral blood preparations by quantitative RT-PCR. Haematologica. 92: 970-3. PMID 17606448 DOI: 10.3324/haematol.11172  0.05
2016 O'Connell RJ, Excler JL, Polonis VR, Ratto-Kim S, Cox J, Jagodzinski LL, Liu M, Wieczorek L, McNeil JG, El-Habib R, Michael NL, Gilliam BL, Paris R, VanCott TC, Tomaras GD, et al. Safety and Immunogenicity of a randomized Phase I prime-boost trial with ALVAC-HIV (vCP205) and Oligomeric gp160 MN/LAI-2 Adjuvanted in Alum or Polyphosphazene. The Journal of Infectious Diseases. PMID 26908741 DOI: 10.1093/infdis/jiw059  0.05
2010 Zhang MY, Borges AR, Ptak RG, Wang Y, Dimitrov AS, Alam SM, Wieczorek L, Bouma P, Fouts T, Jiang S, Polonis VR, Haynes BF, Quinnan GV, Montefiori DC, Dimitrov DS. Potent and broad neutralizing activity of a single chain antibody fragment against cell-free and cell-associated HIV-1. Mabs. 2: 266-74. PMID 20305395 DOI: 10.4161/Mabs.2.3.11416  0.049
2009 Chenine A, Sanders-Buell E, Wieczorek L, Kim J, Polonis V, Tovanabutra S. P19-41. Full-length IMC expressing Renilla luciferase for neutralization assay using PBMC Retrovirology. 6: P361. DOI: 10.1186/1742-4690-6-S3-P361  0.048
2010 Peachman KK, Wieczorek L, Matyas GR, Polonis VR, Alving CR, Rao M. The importance of antibody isotype in HIV-1 virus capture assay and in TZM-bl neutralization. Viral Immunology. 23: 627-32. PMID 21142448 DOI: 10.1089/vim.2010.0061  0.048
1990 Kientsch-Engel R, Hallermayer K, Dessauer A, Wieczorek L. New enzyme-linked immunosorbent assay methods for measurement of serum erythropoietin levels and erythropoietin antibodies. Blood Purification. 8: 255-9. PMID 2091685  0.048
2021 Wuertz KM, Barkei EK, Chen WH, Martinez EJ, Lakhal-Naouar I, Jagodzinski LL, Paquin-Proulx D, Gromowski GD, Swafford I, Ganesh A, Dong M, Zeng X, Thomas PV, Sankhala RS, Hajduczki A, ... ... Wieczorek L, et al. A SARS-CoV-2 spike ferritin nanoparticle vaccine protects against heterologous challenge with B.1.1.7 and B.1.351 virus variants in Syrian golden hamsters. Biorxiv : the Preprint Server For Biology. PMID 34159328 DOI: 10.1101/2021.06.16.448525  0.047
1993 Klinkmann H, Wieczorek L, Scigalla P. Adverse events of subcutaneous recombinant human erythropoietin therapy: results of a controlled multicenter European study. Artificial Organs. 17: 219-25. PMID 8498900  0.046
2009 Wieczorek L, Brown BK, Wesberry M, Ochsenbauer-Jambor C, Kappes JC, Lora N, Gillis A, Nzodom C, Molnar S, Michael NL, Montefiori D, Polonis VR. P04-23. HIV-1 neutralization is impacted by the PBMC donor used for both virus growth and target cells, and the effects are neutralization reagent-specific Retrovirology. 6: P51. DOI: 10.1186/1742-4690-6-S3-P51  0.046
1987 Bicker U, Wieczorek L. [New therapeutic approaches in autoimmune diseases. The goal: selective modification of cell or antibody-mediated immunity]. Fortschritte Der Medizin. 105: 509-12. PMID 3666650  0.044
1987 Bicker U, Wieczorek L. [AIDS--an HIV-induced autoimmune disease?]. Fortschritte Der Medizin. 105: 497-8. PMID 2959603  0.044
1992 Klinkmann H, Schmidt R, Wieczorek L, Scigalla P. Adverse events of subcutaneous recombinant human erythropoietin therapy. Contributions to Nephrology. 100: 127-38. PMID 1458898  0.04
2009 Peachman K, Wieczorek L, Polonis VR, Alving CR, Rao M. P04-19. Analysis of the binding of multiple clades of HIV-1 by a modified virus capture assay Retrovirology. 6: P47.  0.04
2011 Müller KH, Chow E, Wieczorek L, Raguse B, Cooper JS, Hubble LJ. Dynamic response of gold nanoparticle chemiresistors to organic analytes in aqueous solution. Physical Chemistry Chemical Physics : Pccp. 13: 18208-16. PMID 21931887 DOI: 10.1039/c1cp20242a  0.039
2003 Christiansen C, Tankó LB, Warming L, Moelgaard A, Christgau S, Qvist P, Baumann M, Wieczorek L, Hoyle N. Dose dependent effects on bone resorption and formation of intermittently administered intravenous ibandronate. Osteoporosis International : a Journal Established as Result of Cooperation Between the European Foundation For Osteoporosis and the National Osteoporosis Foundation of the Usa. 14: 609-13. PMID 12830369 DOI: 10.1007/s00198-003-1409-0  0.038
2010 Brown BK, Cox J, Gillis A, VanCott TC, Marovich M, Milazzo M, Antonille TS, Wieczorek L, McKee KT, Metcalfe K, Mallory RM, Birx D, Polonis VR, Robb ML. Phase I study of safety and immunogenicity of an Escherichia coli-derived recombinant protective antigen (rPA) vaccine to prevent anthrax in adults. Plos One. 5: e13849. PMID 21079762 DOI: 10.1371/journal.pone.0013849  0.037
2010 Cholin N, Wieczorek L, Romano H, Bernard-Brunel L, Dupuy C, Pétri S, Baubet T. [Care in the very first moments in the event of traumatic loss]. Soins. Psychiatrie. 24-8. PMID 20684469  0.036
1990 Scigalla P, Messinger D, Wieczorek L. Reasons for differences in dose requirements of recombinant human erythropoietin in haemodialysis patients. Contributions to Nephrology. 82: 55-64. PMID 2093527  0.036
2010 Cooper JS, Raguse B, Chow E, Hubble L, Müller KH, Wieczorek L. Gold nanoparticle chemiresistor sensor array that differentiates between hydrocarbon fuels dissolved in artificial seawater. Analytical Chemistry. 82: 3788-95. PMID 20384365 DOI: 10.1021/ac1001788  0.035
2015 Hubble LJ, Cooper JS, Sosa-Pintos A, Kiiveri H, Chow E, Webster MS, Wieczorek L, Raguse B. High-throughput fabrication and screening improves gold nanoparticle chemiresistor sensor performance. Acs Combinatorial Science. 17: 120-9. PMID 25562398 DOI: 10.1021/co500129v  0.034
2015 Cooper JS, Kiiveri H, Hubble LJ, Chow E, Webster MS, Müller KH, Sosa-Pintos A, Bendavid A, Raguse B, Wieczorek L. Quantifying BTEX in aqueous solutions with potentially interfering hydrocarbons using a partially selective sensor array. The Analyst. 140: 3233-8. PMID 25768651 DOI: 10.1039/c5an00223k  0.032
2020 Pitisuttithum P, Nitayaphan S, Chariyalertsak S, Kaewkungwal J, Dawson P, Dhitavat J, Phonrat B, Akapirat S, Karasavvas N, Wieczorek L, Polonis V, Eller MA, Pegu P, Kim D, Schuetz A, et al. Late boosting of the RV144 regimen with AIDSVAX B/E and ALVAC-HIV in HIV-uninfected Thai volunteers: a double-blind, randomised controlled trial. The Lancet. Hiv. PMID 32035516 DOI: 10.1016/S2352-3018(19)30406-0  0.03
2006 Platt SR, Scase TJ, Adams V, Wieczorek L, Miller J, Adamo F, Long S. Vascular endothelial growth factor expression in canine intracranial meningiomas and association with patient survival. Journal of Veterinary Internal Medicine / American College of Veterinary Internal Medicine. 20: 663-8. PMID 16734105 DOI: 10.1892/0891-6640(2006)20[663:VEGFEI]2.0.CO;2  0.029
2009 Weaver KL, Peachman KK, Boonnak K, Wieczorek L, Matyas GR, Asher LM, Polonis VR, Marovich M, Alving CR, Rao M. P04-22. Multispecific monoclonal antibodies bind to primary human macrophages and induce the production of protective chemokines, MIP-1α and MIP-1β Retrovirology. 6: P50.  0.028
1990 Afting EG, Beschle HG, Wieczorek L. [Importance of genetic techniques for diagnosis]. Verhandlungen Der Deutschen Gesellschaft Fã¼R Innere Medizin. 96: 431-8. PMID 2092463  0.025
1992 Plachter B, Wieczorek L, Scholl BC, Ziegelmaier R, Jahn G. Detection of cytomegalovirus antibodies by an enzyme-linked immunosorbent assay using recombinant polypeptides of the large phosphorylated tegument protein pp150. Journal of Clinical Microbiology. 30: 201-6. PMID 1310328  0.023
1988 Hirth P, Wieczorek L, Scigalla P. Molecular biology of erythropoietin. Contributions to Nephrology. 66: 38-53. PMID 3391033  0.023
2017 Ake JA, Schuetz A, Pegu P, Wieczorek L, Eller MA, Kibuuka H, Sawe F, Maboko L, Polonis V, Karasavva N, Weiner D, Sekiziyivu A, Kosgei J, Missanga M, Kroidl A, et al. Safety and Immunogenicity of PENNVAX®-G DNA Prime Administered by Biojector® 2000 or CELLECTRA® Electroporation Device with Modified Vaccinia Ankara-CMDR Boost. The Journal of Infectious Diseases. PMID 28968759 DOI: 10.1093/Infdis/Jix456  0.022
1982 Kayser F, Machka K, Wieczorek L, Banauch D, Bablok W, Braveny I. Evaluation of the Micur microdilution systems for antibiotic susceptibility testing of gram-negative and gram-positive bacteria. European Journal of Clinical Microbiology. 1: 361-6. PMID 7160370  0.02
2012 Hubble LJ, Chow E, Cooper JS, Webster M, Müller KH, Wieczorek L, Raguse B. Gold nanoparticle chemiresistors operating in biological fluids. Lab On a Chip. 12: 3040-8. PMID 22824995 DOI: 10.1039/c2lc40575j  0.02
2001 Cornell BA, Krishna G, Osman PD, Pace RD, Wieczorek L. Tethered-bilayer lipid membranes as a support for membrane-active peptides. Biochemical Society Transactions. 29: 613-7. PMID 11498038  0.016
1999 Cornell BA, Braach-Maksvytis VL, King LG, Osman PD, Raguse B, Wieczorek L, Pace RJ. The gramicidin-based biosensor: a functioning nano-machine. Novartis Foundation Symposium. 225: 231-49; discussion 2. PMID 10472059  0.014
1988 Siebers A, Wieczorek L, Altendorf K. K+-ATPase from Escherichia coli: isolation and characterization. Methods in Enzymology. 157: 668-80. PMID 2976471  0.012
1997 Cornell BA, Braach-Maksvytis VL, King LG, Osman PD, Raguse B, Wieczorek L, Pace RJ. A biosensor that uses ion-channel switches. Nature. 387: 580-3. PMID 9177344 DOI: 10.1038/42432  0.011
1988 Eckardt KU, Kurtz A, Hirth P, Scigalla P, Wieczorek L, Bauer C. Evaluation of the stability of human erythropoietin in samples for radioimmunoassay. Klinische Wochenschrift. 66: 241-5. PMID 3367616  0.011
1983 Bode H, Wielinger H, Wieczorek L. [Antibacterial elements in the urine. Detection with a new test strip]. Zfa. Zeitschrift Fã¼R Allgemeinmedizin. 59: 781-3. PMID 6408822  0.011
2009 Chow E, Herrmann J, Barton CS, Raguse B, Wieczorek L. Inkjet-printed gold nanoparticle chemiresistors: influence of film morphology and ionic strength on the detection of organics dissolved in aqueous solution. Analytica Chimica Acta. 632: 135-42. PMID 19100893 DOI: 10.1016/j.aca.2008.10.070  0.01
2008 Maaroof AI, Cortie MB, Harris N, Wieczorek L. Mie and Bragg plasmons in subwavelength silver semi-shells. Small (Weinheim An Der Bergstrasse, Germany). 4: 2292-9. PMID 19016499 DOI: 10.1002/smll.200800203  0.01
2007 Raguse B, Chow E, Barton CS, Wieczorek L. Gold nanoparticle chemiresistor sensors: direct sensing of organics in aqueous electrolyte solution. Analytical Chemistry. 79: 7333-9. PMID 17722880 DOI: 10.1021/ac070887i  0.01
2007 Platt S, Wieczorek L, Dennis R, De Stefani A. Spinal cord injury resulting from incorrect microchip placement in a cat. Journal of Feline Medicine and Surgery. 9: 157-60. PMID 16982206 DOI: 10.1016/j.jfms.2006.07.002  0.01
2006 Platt SR, De Stefani A, Wieczorek L. Primary orthostatic tremor in a Scottish deerhound. The Veterinary Record. 159: 495-6. PMID 17028254  0.01
2001 Bendavid A, Burns CJ, Field LD, Hashimoto K, Ridley DD, Sandanayake KR, Wieczorek L. Solution- and solid-phase synthesis of components for tethered bilayer membranes. The Journal of Organic Chemistry. 66: 3709-16. PMID 11374989 DOI: 10.1021/jo0057147  0.01
1999 Woodhouse G, King L, Wieczorek L, Osman P, Cornell B. Erratum Journal of Molecular Recognition : Jmr. 12: 335. PMID 10556883 DOI: 10.1002/(SICI)1099-1352(199909/10)12:5<335::AID-JMR487>3.0.CO;2-3  0.01
1999 Woodhouse G, King L, Wieczorek L, Osman P, Cornell B. The ion channel switch biosensor. Journal of Molecular Recognition : Jmr. 12: 328-34. PMID 10556882 DOI: 10.1002/(SICI)1099-1352(199909/10)12:5<328::AID-JMR474>3.0.CO;2-5  0.01
1984 Epstein W, Wieczorek L, Siebers A, Altendorf K. Potassium transport in Escherichia coli: genetic and biochemical characterization of the K+-transporting ATPase. Biochemical Society Transactions. 12: 235-6. PMID 6144601 DOI: 10.1042/Bst0120235  0.01
1983 Kaltwasser F, Kaltwasser G, Banauch D, Wieczorek L. [Determination of antibacterial substances in urine using reagent strips]. Mmw, Mã¼Nchener Medizinische Wochenschrift. 125: 694-6. PMID 6417480  0.01
1979 Wieczorek L, Altendorf K. Potassium transport in Escherichia coli. Evidence for a K+-transport adenosine-5'-triphosphatase. Febs Letters. 98: 233-6. PMID 154416  0.01
Hide low-probability matches.